Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploiting the tumor phenotype using biodegradable submicron carriers of chemotherapeutic drugs.

Critical reviews in oncogenesis - 1 Jan 2014

Geary Sean M, Salem Aliasger K

Abstract excerpt

Tumor tissues possess characteristics that distinguish them from healthy tissues and make them attractive targets for submicron carriers of chemotherapeutic drugs (CTX). CTX are generally administered systemically in free form to cancer patients resulting in unwanted cytotoxic effects and placing limitations on the deliverable CTX dose. In an effort to raise the therapeutic index of CTX there are now...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Drug Carriers
Share to Lactic Acid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liposomes

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 25271435
DOI: 10.1615/critrevoncog.2014011518
PMCID: PMC4183966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploiting the tumor phenotype using biodegradable submicron carriers of chemotherapeutic drugs.PMID 25271435Read ↗

Enhancing Cancer Therapy through Polymeric Nano-particles: Targeted Drug Delivery StrategiesSemantic proximity Read ↗

Ligand conjugated lipid-based nanocarriers for cancer theranosticsSemantic proximity Read ↗

Intrinsically Selective Nanoplatforms for Precision Therapy and MonitoringSemantic proximity Read ↗

Enhancing Therapeutic Outcomes with Smart Drug CarriersSemantic proximity Read ↗

Amino Acid Polymer-Based Nano-Carriers for Targeted Drug Delivery in Breast Cancer Therapy: Mechanisms, Applications, and Future PerspectivesSemantic proximity Read ↗

A Modular Layer-by-Layer Nanoparticle Platform for Hematopoietic Progenitor and Stem Cell TargetingSemantic proximity Read ↗

Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier.Semantic proximity Read ↗

Comprehensive Developments in Targeted Drug Delivery Using Liposomes Nanoparticles and Vesicular SystemsSemantic proximity Read ↗

Design, Synthesis, and Comparison of Pla-Peg-Pla and Peg-Pla-Peg Copolymers for Curcumin Delivery to Cancer CellsSemantic proximity Read ↗

Modular lipid nanoparticle platform technology for siRNA and lipophilic prodrug deliverySemantic proximity Read ↗

The Role of Liposomal Drug Delivery in Modern Medicine and the Expanding Potential of NanocarriersSemantic proximity Read ↗

Machine Learning-Enhanced Engineering of Ultrahigh-Loading Polymer-Drug Assemblies with Programmable ROS-Triggered Release for Tumor EliminationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.